ADAR1 Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

ADAR1 Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	+42,680	New	+$138K	0.05%	167

Other funds holding KRSA

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADAR1 Capital Management's KRSA Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2026: 42,680 shares worth $1.01M. The stake represents 0.05% of the portfolio and ranks #167 among its holdings.

21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

ADAR1 Capital Management held 42,680 shares of Korsana Biosciences, Inc. Common Stock worth $1.01M as of Q2 2026.
Korsana Biosciences, Inc. Common Stock was a new ADAR1 Capital Management position in Q2 2026.
Korsana Biosciences, Inc. Common Stock made up 0.05% of ADAR1 Capital Management's portfolio in Q2 2026, its #167 holding.
21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.